Clinical trial · Interventional
Comparison of Perioperative Outcomes Between Energy Device During Laparoscopic Gastrectomy
Comparison of Perioperative Outcomes Between Bipolar Sealing Device and Ultrasonic Shears During Laparoscopic Gastrectomy for Early Gastric Cancer
NCT03356626CI-TRIAL-00080968completedN/AResults postedClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
To find out which instrument can be much better for laparoscopic gastrectomy among Harmonic scalpel, Ligasure Maryland, Thunderbeat comparing postoperative CRP level in each group
Conditions
Conditions (2)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Postoperative Fever | — | UNRESOLVED | — |
| Postoperative Inflammation | — | UNRESOLVED | — |
Interventions
Interventions (3)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Ligasure Maryland | Device | — | UNRESOLVED |
| Thunderbeat | Device | — | UNRESOLVED |
| ULTRACISION Harmonic Scalpel | Device | — | UNRESOLVED |
Design
Arms and outcomes
Arms (3)
- type
- EXPERIMENTAL
- label
- ULTRACISION Harmonic Scalpel
- description
- Patients group randomized to use ULTRACISION Harmonic Scalpel when receives laparoscopic gastrectomy
- interventionNames
- Device: ULTRACISION Harmonic Scalpel
- type
- EXPERIMENTAL
- label
- Ligasure Maryland
- description
- Patients group randomized to use Ligasure Maryland when receives laparoscopic gastrectomy
- interventionNames
- Device: Ligasure Maryland
- type
- EXPERIMENTAL
- label
- Thunderbeat
- description
- Patients group randomized to use Thunderbeat when receives laparoscopic gastrectomy
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 20 Years
- Maximum age
- 80 Years
Show eligibility criteria text
Inclusion Criteria: * pathologically proven adenocarcinoma in stomach * patients who are expected for R0 resection with distal gastrectomy * pre-operative clinical stage should be stage I * patients who is able to be followed up with in postoperative 30 days * patients whose CRP is normal before surgery Exclusion Criteria: * patients who had an abdominal surgery * patients who received chemotherapy, radiotherapy before surgery * patients who received ESD before surgery * Patients who had an ascites on pre-operative CT scan * liver cirrhosis * cardiovascular disease (Ejection Fraction\<50%) * serum creatinine \> 1.4 mg/dL or BUN\>26mg/dL * PT INR \>1.2 or aPTT\>45sec * uncontrolled diabetes * Crohn's disease, ulcerative colitis * patients who receives anti-coagulants * patients who need pre-operative steroid booster because of steroid treatment * pregnancy * patients who have allergic reaction to iodine
References
Publications (0)
Data not yet available
No reference posted for this study.